Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Striyker who wrote (1631)	6/23/1998 2:29:00 PM
From: Striyker	Respond to of 5402

Some general info from yahoo: Sanguine Corporation OTC BB : SGNC Address: 101 East Green Street, #11 Pasadena, CA 91105 Phone: (626) 405-0079 Industry: Biotechnology & Drugs Sector: Healthcare Employees: 2 Officers: Thomas C. Drees Ph.D., Chmn./Pres./CEO David E. Nelson, CFO Anthony G. Hargreaves, VP/Secy./Treas. Business Summary Sanguine Corporation, a development stage company, is engaged in the development of a synthetic red blood cell product called PHER-02, a second generation version of Fluosol, the only FDA-approved synthetic blood product to date. For the three months ended 3/31/98, the Company reported no revenues. Net loss fell 38% to $37 thousand. Lower loss reflects lower research and development expenses and the absence of $12 thousand in consultant fees. Statistics at a Glance -- SGNC Last Updated: June 19, 1998 Price and Volume (updated June 19, 1998) 52-Week Low $0.188 Recent Price $0.844 52-Week High $1.031 Beta N/A Daily Volume (3-month avg) 955 Share-Related Items Market Capitalization $17.7M Shares Outstanding 21.0M Float 7.80M Dividend Information Annual Dividend none Per-Share Data Book Value (mrq) -$0.03 Earnings (ttm) -$0.01 Sales N/A Cash N/A Valuation Ratios Price/Book N/A Price/Earnings N/A Price/Sales N/A Income Statements Net Income (ttm) -$144.0K Sales N/A Profitability Profit Margin N/A Management Effectiveness Return on Assets (ttm) -1800.00% Return on Equity N/A Financial Strength Current Ratio N/A Total Debt/Equity N/A See the Profile FAQ for a description of each item above; K = thousands; M = millions; mrq = most-recent quarter; ttm = trailing twelve months through Mar 31, 1998